Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
5.20
+2.19 (72.76%)
At close: Nov 7, 2025

RAJAF Revenue

In the year 2025, Cordyceps Sunshine Biotech Holdings had annual revenue of $1.25M, down -0.65%. Cordyceps Sunshine Biotech Holdings had revenue of $315.50K in the quarter ending December 31, 2023, with 210.58% growth.

Revenue
1.25M
Revenue Growth
+2,236.31%
P/S Ratio
463.99
Revenue / Employee
95.80K
Employees
13
Market Cap
577.82M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.25M-8.14K-0.65%
Dec 31, 20241.25M370.95K42.03%
Dec 31, 2023882.53K829.23K1,555.66%
Dec 31, 202253.30K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition